These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 25747602)

  • 21. Intervention with exercise restores motor deficits but not nigrostriatal loss in a progressive MPTP mouse model of Parkinson's disease.
    Sconce MD; Churchill MJ; Greene RE; Meshul CK
    Neuroscience; 2015 Jul; 299():156-74. PubMed ID: 25943481
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Temporal mRNA profiles of inflammatory mediators in the murine 1-methyl-4-phenyl-1,2,3,6-tetrahydropyrimidine model of Parkinson's disease.
    Pattarini R; Smeyne RJ; Morgan JI
    Neuroscience; 2007 Mar; 145(2):654-68. PubMed ID: 17258864
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Altered glutamate release in the dorsal striatum of the MitoPark mouse model of Parkinson's disease.
    Farrand AQ; Gregory RA; Bäckman CM; Helke KL; Boger HA
    Brain Res; 2016 Nov; 1651():88-94. PubMed ID: 27659966
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effect of oestrogen receptors on brain NMDA receptors of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine mice.
    Al-Sweidi S; Morissette M; Di Paolo T
    J Neuroendocrinol; 2012 Nov; 24(11):1375-85. PubMed ID: 22672467
    [TBL] [Abstract][Full Text] [Related]  

  • 25. MPTP-induced parkinsonism in mice alters striatal and nigral xCT expression but is unaffected by the genetic loss of xCT.
    Bentea E; Sconce MD; Churchill MJ; Van Liefferinge J; Sato H; Meshul CK; Massie A
    Neurosci Lett; 2015 Apr; 593():1-6. PubMed ID: 25766755
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Role of NMDA receptor subtypes in the induction of catalepsy and increase in Fos protein expression after administration of haloperidol.
    Yanahashi S; Hashimoto K; Hattori K; Yuasa S; Iyo M
    Brain Res; 2004 Jun; 1011(1):84-93. PubMed ID: 15140647
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Microglial activation and age-related dopaminergic neurodegeneration in MPTP-treated SAMP8 mice.
    Liu J; Wang MW; Gu P; Ma QY; Wang YY; Geng Y; Yuan ZY; Cui DS; Zhang ZX; Ma L; Zhang BH; Zhou MG; Zhu AP
    Brain Res; 2010 Jul; 1345():213-20. PubMed ID: 20546706
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effect of MPTP-induced denervation on basal ganglia GABA(B) receptors: correlation with dopamine concentrations and dopamine transporter.
    Calon F; Lavertu N; Lemieux AM; Morissette M; Goulet M; Grondin R; Blanchet PJ; Bédard PJ; Di Paolo T
    Synapse; 2001 Jun; 40(3):225-34. PubMed ID: 11304760
    [TBL] [Abstract][Full Text] [Related]  

  • 29. An influence of ligands of metabotropic glutamate receptor subtypes on parkinsonian-like symptoms and the striatopallidal pathway in rats.
    Ossowska K; Konieczny J; Wardas J; Pietraszek M; Kuter K; Wolfarth S; Pilc A
    Amino Acids; 2007 Feb; 32(2):179-88. PubMed ID: 16699817
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Swim-test as a function of motor impairment in MPTP model of Parkinson's disease: a comparative study in two mouse strains.
    Haobam R; Sindhu KM; Chandra G; Mohanakumar KP
    Behav Brain Res; 2005 Sep; 163(2):159-67. PubMed ID: 15941598
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Cannabinoid CB(1) receptors in the basal ganglia and motor response to activation or blockade of these receptors in parkin-null mice.
    González S; Mena MA; Lastres-Becker I; Serrano A; de Yébenes JG; Ramos JA; Fernández-Ruiz J
    Brain Res; 2005 Jun; 1046(1-2):195-206. PubMed ID: 15882845
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Pain perception in acute model mice of Parkinson's disease induced by 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP).
    Park J; Lim CS; Seo H; Park CA; Zhuo M; Kaang BK; Lee K
    Mol Pain; 2015 May; 11():28. PubMed ID: 25981600
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Electrophysiological and behavioral evidence that modulation of metabotropic glutamate receptor 4 with a new agonist reverses experimental parkinsonism.
    Beurrier C; Lopez S; Révy D; Selvam C; Goudet C; Lhérondel M; Gubellini P; Kerkerian-LeGoff L; Acher F; Pin JP; Amalric M
    FASEB J; 2009 Oct; 23(10):3619-28. PubMed ID: 19525404
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effect of caffeine on the expression of cytochrome P450 1A2, adenosine A2A receptor and dopamine transporter in control and 1-methyl 4-phenyl 1, 2, 3, 6-tetrahydropyridine treated mouse striatum.
    Singh S; Singh K; Gupta SP; Patel DK; Singh VK; Singh RK; Singh MP
    Brain Res; 2009 Aug; 1283():115-26. PubMed ID: 19520064
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Functional modulation of G-protein coupled receptors during Parkinson disease-like neurodegeneration.
    Jenkins BG; Zhu A; Poutiainen P; Choi JK; Kil KE; Zhang Z; Kuruppu D; Aytan N; Dedeoglu A; Brownell AL
    Neuropharmacology; 2016 Sep; 108():462-73. PubMed ID: 26581500
    [TBL] [Abstract][Full Text] [Related]  

  • 36. MPEP, an mGlu5 receptor antagonist, reduces the development of L-DOPA-induced motor complications in de novo parkinsonian monkeys: biochemical correlates.
    Morin N; Grégoire L; Morissette M; Desrayaud S; Gomez-Mancilla B; Gasparini F; Di Paolo T
    Neuropharmacology; 2013 Mar; 66():355-64. PubMed ID: 22884464
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Dysfunction of the cortico-basal ganglia-cortical loop in a rat model of early parkinsonism is reversed by metabotropic glutamate receptor 5 antagonism.
    Oueslati A; Breysse N; Amalric M; Kerkerian-Le Goff L; Salin P
    Eur J Neurosci; 2005 Dec; 22(11):2765-74. PubMed ID: 16324110
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Ginkgo biloba extract (EGb 761) modulates the expression of dopamine-related genes in 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced Parkinsonism in mice.
    Rojas P; Ruiz-Sánchez E; Rojas C; Ogren SO
    Neuroscience; 2012 Oct; 223():246-57. PubMed ID: 22885234
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effect of a chronic treatment with an mGlu5 receptor antagonist on brain serotonin markers in parkinsonian monkeys.
    Morin N; Morissette M; Grégoire L; Di Paolo T
    Prog Neuropsychopharmacol Biol Psychiatry; 2015 Jan; 56():27-38. PubMed ID: 25046277
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The effect of striatal pre-enkephalin overexpression in the basal ganglia of the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine mouse model of Parkinson's disease.
    Bissonnette S; Muratot S; Vernoux N; Bezeau F; Calon F; Hébert SS; Samadi P
    Eur J Neurosci; 2014 Jul; 40(2):2406-16. PubMed ID: 24750443
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.